Mark McLaughlin
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Chemistry and Chemical Engineering, History and advancements in chemistry, HIV/AIDS drug development and treatment, Asymmetric Hydrogenation and Catalysis, Crystallization and Solubility Studies
Most-Cited Works
- → Design of an in vitro biocatalytic cascade for the manufacture of islatravir(2019)616 cited
- → Efficient Access to Azaindoles and Indoles(2006)127 cited
- → A Simple, Modular Method for the Synthesis of 3,4,5-Trisubstituted Pyrazoles(2008)65 cited
- → Enantioselective Synthesis of 4′-Ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) via Enzymatic Desymmetrization(2017)64 cited
- → Enantioselective Rh(I)-Catalyzed Addition of Arylboronic Acids to Cyclic Ketimines(2015)41 cited
- → Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic Pain(2014)41 cited
- → Practical Synthesis of Functionalized 1,5-Disubstituted 1,2,4-Triazole Derivatives(2010)38 cited
- → Mobile Tool for HPLC Reaction Monitoring(2007)37 cited
- → A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies(2017)33 cited
- → Practical Asymmetric Synthesis of a Chiral Piperazinone Derivative(2013)30 cited